Format

Send to

Choose Destination
PLoS One. 2018 Jan 18;13(1):e0191230. doi: 10.1371/journal.pone.0191230. eCollection 2018.

Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry.

Author information

1
Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
2
Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
3
Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
4
MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom.
5
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
6
Faculty of Environment and Information Studies, Keio University, Fujisawa, Kanagawa, Japan.
7
Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, South Kensington, London, United Kingdom.

Abstract

BACKGROUND:

Cohort studies with metabolomics data are becoming more widespread, however, large-scale studies involving 10,000s of participants are still limited, especially in Asian populations. Therefore, we started the Tsuruoka Metabolomics Cohort Study enrolling 11,002 community-dwelling adults in Japan, and using capillary electrophoresis-mass spectrometry (CE-MS) and liquid chromatography-mass spectrometry. The CE-MS method is highly amenable to absolute quantification of polar metabolites, however, its reliability for large-scale measurement is unclear. The aim of this study is to examine reproducibility and validity of large-scale CE-MS measurements. In addition, the study presents absolute concentrations of polar metabolites in human plasma, which can be used in future as reference ranges in a Japanese population.

METHODS:

Metabolomic profiling of 8,413 fasting plasma samples were completed using CE-MS, and 94 polar metabolites were structurally identified and quantified. Quality control (QC) samples were injected every ten samples and assessed throughout the analysis. Inter- and intra-batch coefficients of variation of QC and participant samples, and technical intraclass correlation coefficients were estimated. Passing-Bablok regression of plasma concentrations by CE-MS on serum concentrations by standard clinical chemistry assays was conducted for creatinine and uric acid.

RESULTS AND CONCLUSIONS:

In QC samples, coefficient of variation was less than 20% for 64 metabolites, and less than 30% for 80 metabolites out of the 94 metabolites. Inter-batch coefficient of variation was less than 20% for 81 metabolites. Estimated technical intraclass correlation coefficient was above 0.75 for 67 metabolites. The slope of Passing-Bablok regression was estimated as 0.97 (95% confidence interval: 0.95, 0.98) for creatinine and 0.95 (0.92, 0.96) for uric acid. Compared to published data from other large cohort measurement platforms, reproducibility of metabolites common to the platforms was similar to or better than in the other studies. These results show that our CE-MS platform is suitable for conducting large-scale epidemiological studies.

PMID:
29346414
PMCID:
PMC5773198
DOI:
10.1371/journal.pone.0191230
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center